- Home
- MGIC vs ICUCW Comparison
MGIC vs ICUCW Comparison
Compare MGIC & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MGIC | ICUCW |
|---|---|---|
| Founded | 1983 | N/A |
| Country | Israel | United States |
| Employees | N/A | 18 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 990.3M | N/A |
| IPO Year | 1991 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MGIC | ICUCW |
|---|---|---|
| Price | $26.28 | $0.01 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 42.3K | N/A |
| Earning Date | 11-18-2025 | N/A |
| Dividend Yield | ★ 2.29% | N/A |
| EPS Growth | ★ 16.15 | N/A |
| EPS | ★ 0.81 | N/A |
| Revenue | ★ $603,216,000.00 | N/A |
| Revenue This Year | $12.87 | N/A |
| Revenue Next Year | $6.23 | N/A |
| P/E Ratio | $32.45 | ★ N/A |
| Revenue Growth | ★ 12.65 | N/A |
| 52 Week Low | $11.36 | N/A |
| 52 Week High | $27.44 | N/A |
Technical Indicators
Market Signals| Indicator | MGIC | ICUCW |
|---|---|---|
| Relative Strength Index (RSI) | 56.99 | 39.26 |
| Support Level | $26.25 | $0.01 |
| Resistance Level | $26.95 | $0.01 |
| Average True Range (ATR) | 0.71 | 0.00 |
| MACD | -0.12 | 0.00 |
| Stochastic Oscillator | 62.33 | 44.44 |
Price Performance
Historical ComparisonAbout MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.